Background: The SAMe-TT2R2 score identifies patients on vitamin K antagonists (VKAs)
who are more likely to have poor time in therapeutic range (TTR); however, the association …

Identifying patients who are likely to achieve and maintain a therapeutic international
normalized ratio when prescribed a vitamin K antagonist for stroke prevention in atrial …

Background: The safety and effectiveness of warfarin depend on anticoagulation control
quality. Observational studies associate poor control with increased morbidity, mortality and …

Background In many low-to middle-income countries in Asia, patients with NVAF usually
received warfarin for thromboembolic prevention due to cost-effectiveness. The SAMe …

Background It is estimated that atrial fibrillation (AF) affects approximately 1.5 million people
in Brazil; however, epidemiological data are limited. We sought to evaluate the …

Background Sex, age, medical history, treatment, tobacco use, and race (SAMe-TT2R2)
score helps detect patients at risk of suboptimal anticoagulation control. A score above two …

Abstract The 2012 American College of Chest Physicians' guidelines recommended a 12-
week INR follow-up interval may be appropriate for patients on stable warfarin doses …

There is no strong evidence on pharmacogenetics role on the quality of INR control after the
initiation phase and on the maintenance of stable INR on the long term as measured by the …

Background: Data on the use of direct oral anticoagulants in the setting of bioprosthetic
valve replacements is limited. Objective: The purpose of this study was to describe outcomes …

Мета роботи–визначити вплив клінічних і генетичних чинників на стабільність
антикоагуляції варфарином у хворих із фібриляцією передсердь (ФП) протягом року …